Letters BS in our name stand for the “BEST SOLUTION” and this is why EAST BS Clinical Research is the best solution in this region:

  • Centralized healthcare system which enables us to access larger pools of patients at each site
  • Limited access to newer therapies- this is the reason why our patients are more willing to participate in clinical trials
  • Our team has extensive experience in managing large international studies
  • We can offer investigational sites with high recruitment rate
  • We are familiar with local Regulatory and EC requirements

Many years of experience are our most valuable asset. All our services are provided by highly trained professionals. We provide services for startup, managing, monitoring and reporting on the studies conducted at multiple centers around the region. We are proud of our insight into local potentials and very good relationships with all relevant investigators in the region. This is the reason why we are successful not only in performing quality feasibility analyses but also in achieving and maintaining very high recruitment rate. Our Clinical Operations team is capable of conducting all aspects of the clinical monitoring and maintaining the high quality of work under all circumstances.

EAST BS Clinical Research has never had a trial contract cancelled or suspended, many clients have signed up for services more than once. In fact, a significant minority of its contracted opportunities have come from ‘rescue’ operations, taking over clinical trial responsibilities from CROs which have not performed according to project plans or expectations. Considerable number of referrals have come from CROs we previously collaborated with, which is an important indication of ‘peer certification’. Finally, EAST BS Clinical Research has successfully passed all audits performed by its clients and by independent authorities.

While EAST BS Clinical Research prides itself on providing wide range of services, the company has particular experience in working with biotech. EAST BS Clinical Research is well placed to collaborate with emerging and developing companies in this sector.